2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
- PMID: 37471501
- DOI: 10.1161/CIR.0000000000001168
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Erratum in
-
Correction to: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation. 2023 Sep 26;148(13):e148. doi: 10.1161/CIR.0000000000001183. Epub 2023 Sep 25. Circulation. 2023. PMID: 37747957 No abstract available.
-
Correction to: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation. 2023 Dec 5;148(23):e186. doi: 10.1161/CIR.0000000000001195. Epub 2023 Dec 4. Circulation. 2023. PMID: 38048397 No abstract available.
Abstract
Aim: The "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease" provides an update to and consolidates new evidence since the "2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease" and the corresponding "2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease."
Methods: A comprehensive literature search was conducted from September 2021 to May 2022. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.
Structure: This guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. Relevant topics include general approaches to treatment decisions, guideline-directed management and therapy to reduce symptoms and future cardiovascular events, decision-making pertaining to revascularization in patients with chronic coronary disease, recommendations for management in special populations, patient follow-up and monitoring, evidence gaps, and areas in need of future research. Where applicable, and based on availability of cost-effectiveness data, cost-value recommendations are also provided for clinicians. Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.
Keywords: AHA Scientific Statements; acute coronary syndrome; air pollution; angina; antiplatelet therapy; aspirin; atherosclerosis; autoimmune diseases; cardiac events; cardiac rehabilitation; cardiovascular diseases; colchicine; coronary artery disease; coronary disease; cost-benefit analysis; depression; diabetes; diet; diet therapy; dietary supplements; drug therapy; dual antiplatelet therapy; environmental exposure; exercise tolerance; factor Xa inhibitors; fibrinolytic agents; glucagon-like peptide-1 receptor agonists; guideline-directed management and therapy; health care outcome assessments; health equity; heart disease risk factors; heart failure; hormone replacement therapy; hypercholesterolemia; hypertension; immunization; ischemic heart disease; mental health; multidisciplinary; myocardial ischemia; outcomes; outpatient; patient care team; pharmacology; pregnancy; proton pump inhibitors; quality of life; safety; secondary prevention; sexual behavior; sexual health; shared decision-making; smoking cessation; social determinants of health; sodium-glucose cotransporter 2 inhibitors; spontaneous coronary artery dissection; stress; therapeutic use; therapy; type 2 diabetes; vaccination.
Similar articles
-
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2023 Aug 29;82(9):833-955. doi: 10.1016/j.jacc.2023.04.003. Epub 2023 Jul 20. J Am Coll Cardiol. 2023. PMID: 37480922
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29. Circulation. 2016. PMID: 27026020 Review. No abstract available.
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2022 May 3;79(17):1757-1780. doi: 10.1016/j.jacc.2021.12.011. Epub 2022 Apr 1. J Am Coll Cardiol. 2022. PMID: 35379504
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1. Circulation. 2022. PMID: 35363500 Review.
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1. Circulation. 2022. PMID: 35363499 Review.
Cited by
-
High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study.Cardiovasc Diabetol. 2024 Jun 1;23(1):190. doi: 10.1186/s12933-024-02286-z. Cardiovasc Diabetol. 2024. PMID: 38824608 Free PMC article.
-
Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease.Cardiovasc Diabetol. 2024 May 31;23(1):187. doi: 10.1186/s12933-024-02230-1. Cardiovasc Diabetol. 2024. PMID: 38822373 Free PMC article.
-
A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions.J Pers Med. 2024 May 10;14(5):506. doi: 10.3390/jpm14050506. J Pers Med. 2024. PMID: 38793088 Free PMC article. Review.
-
Systemic Capillary Responses to Acute Exercise in Hypertensive Seniors: Insights from a Single-Center Pilot Study.J Clin Med. 2024 May 10;13(10):2818. doi: 10.3390/jcm13102818. J Clin Med. 2024. PMID: 38792358 Free PMC article.
-
Impact of CYP2C19 Gene Variants on Long-Term Treatment with Atorvastatin in Patients with Acute Coronary Syndromes.Int J Mol Sci. 2024 May 15;25(10):5385. doi: 10.3390/ijms25105385. Int J Mol Sci. 2024. PMID: 38791422 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous